These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24464269)
1. Effect of crystallinity on electrostatic charging in dry powder inhaler formulations. Wong J; Kwok PC; Noakes T; Fathi A; Dehghani F; Chan HK Pharm Res; 2014 Jul; 31(7):1656-64. PubMed ID: 24464269 [TBL] [Abstract][Full Text] [Related]
2. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance. Son YJ; Worth Longest P; Hindle M Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343 [TBL] [Abstract][Full Text] [Related]
3. Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors. Telko MJ; Hickey AJ AAPS PharmSciTech; 2014 Dec; 15(6):1378-97. PubMed ID: 24938617 [TBL] [Abstract][Full Text] [Related]
4. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying. Saboti D; Maver U; Chan HK; Planinšek O J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading. Du P; Du J; Smyth HDC J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234 [TBL] [Abstract][Full Text] [Related]
6. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent? Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239 [TBL] [Abstract][Full Text] [Related]
7. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler. Kaialy W; Nokhodchi A Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603 [TBL] [Abstract][Full Text] [Related]
8. Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure. Leung CMS; Tong Z; Zhou QT; Chan JGY; Tang P; Sun S; Yang R; Chan HK AAPS J; 2016 Sep; 18(5):1159-1167. PubMed ID: 27161214 [TBL] [Abstract][Full Text] [Related]
9. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers. Jetmalani K; Young PM; Smith T; Stewart P; Traini D Drug Dev Ind Pharm; 2012 Dec; 38(12):1504-11. PubMed ID: 22335558 [TBL] [Abstract][Full Text] [Related]
10. Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols. Yu J; Wong J; Ukkonen A; Kannosto J; Chan HK Pharm Res; 2017 Aug; 34(8):1707-1715. PubMed ID: 28540500 [TBL] [Abstract][Full Text] [Related]
11. The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems. Hoe S; Traini D; Chan HK; Young PM Pharm Res; 2010 Jul; 27(7):1325-36. PubMed ID: 20354768 [TBL] [Abstract][Full Text] [Related]
12. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation. Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940 [TBL] [Abstract][Full Text] [Related]
13. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems. Young PM; Sung A; Traini D; Kwok P; Chiou H; Chan HK Pharm Res; 2007 May; 24(5):963-70. PubMed ID: 17377746 [TBL] [Abstract][Full Text] [Related]
14. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying. Lu W; Rades T; Rantanen J; Yang M Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050 [TBL] [Abstract][Full Text] [Related]
15. Development of dry salbutamol sulfate powder with high inhalation performance independent of inhalation patterns. Hira D; Okuda T; Ichihashi M; Kojima H; Okamoto H Chem Pharm Bull (Tokyo); 2012; 60(3):334-40. PubMed ID: 22382413 [TBL] [Abstract][Full Text] [Related]
16. The effect of relative humidity on electrostatic charge decay of drugs and excipient used in dry powder inhaler formulation. Elajnaf A; Carter P; Rowley G Drug Dev Ind Pharm; 2007 Sep; 33(9):967-74. PubMed ID: 17891583 [TBL] [Abstract][Full Text] [Related]
17. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. Dhumal RS; Biradar SV; Paradkar AR; York P Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462 [TBL] [Abstract][Full Text] [Related]
19. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices. Ooi J; Gill C; Young PM; Traini D Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438 [TBL] [Abstract][Full Text] [Related]
20. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol. Kaialy W; Nokhodchi A Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]